Author: Agnieszka Kubicka-Trz_ska (Poland)
Co-authors: Katarzyna Żuber-Łaskawiec, Izabella Karska-Basta, Hanna Plutecka, Bożena Romanowska-Dixon, Marek Sanak
Purpose
To investigate the serum concentrations of the key autophagy regulators Beclin-1 and mTOR (mammalian target of rapamycin) in patients with exudative age-related macular degeneration (AMD).
Setting/Venue
The retrospective case-control study.
Methods
The study included 38 treatment-naïve patients with exudative AMD and 36 sex- and age-matched healthy controls scheduled for senile cataract surgery. The individuals with concomitant ocular disorders or systemic comorbidities possibly involving autophagy in the pathogenesis were excluded from the study. Serum levels of Beclin-1 and mTOR were detected using an enzyme-linked immunosorbent assay. Associations between serum proteins levels and age, sex, duration of ocular symptoms, as well as angiographic and optical coherence tomography findings were assessed.
Results
The results of our study showed that Beclin-1 serum levels were lower in patients with AMD than in controls (median, 0.100 ng/ml vs 1.123 ng/ml; p=0.0033), while mTOR levels were nonsignificantly higher compared with controls (median, 4.377 ng/ml vs 3.608 ng/ml; p=0.4522). In both analysed groups, participants older than 70 years showed lower Beclin-1 levels than those aged 70 years or younger (p=0.0444) and this was mostly noted in patients with AMD (p=0.0024). Serum mTOR levels increased with age and there were no differences in the number of individuals between groups regarding this observation (p=0.2316). In patients with AMD, lower mTOR levels were associated with drusen, while higher levels were observed in those with a fibrous scar in the contralateral eye (p=0.0212).
Conlusions
The findings of this study suggest that significantly decreased serum levels of Beclin-1 as compared with healthy controls may reflect a reduction of autophagy capacity in patients with advanced stages of exudative AMD. Additionally, higher serum mTOR levels detected in older individuals may be related to the downregulation of autophagy mechanisms occuring with aging.
Financial Disclosure
This work was supported by Jagiellonian University Medical College grant (no. N41/DBS/000310 to A. Kubicka-Trząska). The authors declare no conflict of interest. None of the authors has any financial disclosure in relation to this manuscript.
Comments
-